Please wait a minute...
European Journal of Gynaecological Oncology  2021, Vol. 42 Issue (1): 105-109    DOI: 10.31083/j.ejgo.2021.01.2269
Original Research Previous articles | Next articles
The prevalence of abnormal pap smear in women with pelvic inflammatory disease and determine the risk factors of cervical intra-epithelial neoplasia 2/3
Hye-yon Cho1, Soobin Yim1, Inji Yeo1, Min Sun Kyung1, *()
1Hallym University Dogtan Sacred Heart Hospital, Keunjaebong-gil 7, Hwaseong-si, 18450 Kyonggi-do, Korea
Download:  PDF(627KB)  ( 47 ) Full text   ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To investigate the prevalence of abnormal Pap (ASCUS or worse) and HPV infection in women with pelvic inflammatory disease (PID) and assess the risk factors for CIN2/3. Methods: Retrospective chart review of 249 women who were admitted to the hospital for the treatment of PID between 2013 and 2019 was performed. Patients' characteristics including age, parity, sexually transmitted disease (STD) infection, Pap results, human papilloma virus (HPV) infection, Nugent score, C-reactive protein (CRP), and neutrophil to lymphocyte ratio (NLR) were retrieved. Clinical characteristics were compared between group 1 (women with normal pap; N = 159) and group 2 (women with abnormal Pap; N = 90). Results: Of 249 women, abnormal Pap rate was 36.1% and HPV positivity was 41.0%. Of those with HPV infection, 78.4% had high-risk HPV subtypes. Group 2 was significantly associated with high-risk HPV infection (P < 0.0001) and low NLR (P = 0.047). 74 women underwent colposcopy-directed punch biopsy, and 14 showed CIN2/3. Multivariate analysis showed that high-risk HPV infection (P = 0.040; 95% CI 1.081-32.389) and low Nugent score (≤ 3) (P = 0.003; 95% CI 2.130-39.807) were independent risk factors of CIN2/3 in women with abnormal Pap and PID. Conclusions: Women with PID showed high prevalence of abnormal Pap. Nonetheless, high-risk HPV infection and low Nugent score are the most reliable factors in determining colposcopy for the diagnosis of CIN2/3.
Key words:  Abnormal Pap      Cervical intraepithelial neoplasia (CIN)      Human papilloma virus (HPV)      Pelvic inflammatory disease (PID)     
Submitted:  12 October 2020      Revised:  18 November 2020      Accepted:  19 November 2020      Published:  15 February 2021     
*Corresponding Author(s):  Min Sun Kyung     E-mail:  msfeel@hallym.or.kr

Cite this article: 

Hye-yon Cho, Soobin Yim, Inji Yeo, Min Sun Kyung. The prevalence of abnormal pap smear in women with pelvic inflammatory disease and determine the risk factors of cervical intra-epithelial neoplasia 2/3. European Journal of Gynaecological Oncology, 2021, 42(1): 105-109.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2021.01.2269     OR     https://ejgo.imrpress.com/EN/Y2021/V42/I1/105

[1] F. Liu, D.H. Hu, M.J. Fei, Y.F. Zhang, B. Wang, C.Y. Wang, K. Huang. Evaluation of p16/Ki67 dual staining compared with high-risk HPV testing to assess liquid-based cytology with atypical squamous cells of unknown significance[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 249-253.
[2] Yujie Chen, Jing Chen, Lan Yang, Yanming Jiang, Li Li, Wenjuan Yi, Lifang Lan, Liuhong Zhang. Lower genital tract infection and other factors associated with cervial intraepithelial neoplasia: a hospital-base case-control study[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 795-799.
[3] Hong Ma, Yumei Li, Zhiqiang Chen, Liping Liu, Hui Xu, Xiaoyue Yang. Distribution of HPV genotypes and the relationship with CIN[J]. European Journal of Gynaecological Oncology, 2017, 38(4): 601-606.
[4] X. Kong, L.J. Ding, Z.X. Wang. Mucin expression profile of benign and malignant cervical tissues and correlation with clinical-pathologic parameters[J]. European Journal of Gynaecological Oncology, 2017, 38(3): 350-355.
No Suggested Reading articles found!